38 research outputs found
Biopsy-proven lymph nodes predict axillary nodal response following neoadjuvant chemotherapy in node-positive breast cancer.
No full textMy surgical practice: Presenting aesthetic flat closure as an equal option to mastectomy with reconstruction and technical considerations to optimize cosmesis.
No full textASO Author Reflections: Optimizing Breast Cancer Risk Assessment and Screening Among Black Women.
No full textASO Author Reflections: Reinforcing the Safety Net: Supporting Safety-Net Hospitals in Mitigating Breast Cancer Disparities.
No full textInvited Editorial on Breast Surgical Oncology Epidemiological Research: A Guide and Comparison of Four National Databases.
No full textDiversity, Equity, and Inclusion in Clinical Trials.
No full textMinority groups are vastly underrepresented in clinical trial participants and leadership. Because these studies provide innovative and revolutionary treatment options to patients with cancer and have the potential to extend survival, it is imperative that public and private stakeholders, as well as hospital and clinical trial leadership, prioritize equity and inclusion of diverse populations in clinical trial development and recruitment strategies. Achieving equity in clinical trials could be an important step in reducing the overall cancer burden and mortality disparities in vulnerable populations
ASO Author Reflections: Oncoplastic Surgery Facilitates Breast Conservation and May Permit More Judicious Chemotherapy Use.
No full text
